U.S. market Closed. Opens in 6 hours 4 minutes

DRTSW | Alpha Tau Medical Ltd. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
RevenueN/AN/AN/AN/AN/AN/AN/AN/AN/A
Cost of Revenue1.07MN/AN/A979.00KN/A776.00KN/A86.00KN/A
Gross Profit-1.07MN/AN/A-979.00KN/A-776.00KN/A-86.00KN/A
Operating Expenses-35.68M33.72M32.14M32.14M13.79M13.79M9.24M9.24M8.01M
Selling, General & Admin9.26M9.41M11.25M11.25M2.34M2.34M1.70M1.70M1.37M
Research & Development27.27M24.31M20.89M20.89M11.45M11.45M7.54M7.54M6.64M
Other Operating Expenses-72.20MN/AN/AN/AN/AN/AN/AN/AN/A
Operating Income35.68M-33.72M-32.14M-32.14M-13.79M-13.79M-9.24M-9.24M-8.01M
Other Expenses / Income-64.82M8.54M-1.61M-1.61M-13.47M-13.47M520.00K520.00K-308.00K
Before Tax Income-29.14M-25.18M-33.74M-33.74M-27.26M-27.26M-8.72M-8.72M-8.32M
Income Tax Expenses16.00K11.00K20.00K20.00K7.00K7.00K158.00K158.00K146.00K
Net Income-29.16M-25.19M-33.76M-33.76M-27.27M-27.27M-8.88M-8.88M-8.46M
Interest Expenses39.00KN/A1.77M1.77MN/A13.27MN/A217.00KN/A
Basic Shares Outstanding69.38MN/A63.53M63.53M67.62M40.53M67.62M40.43M67.62M
Diluted Shares Outstanding69.38MN/A63.53M63.53M67.62M40.53M67.62M40.43M67.62M
EBITDA-34.61M-30.35M-32.14M-32.14M-13.79M-13.79M-9.06M-9.06M-6.87M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
EBIT-29.10M-25.18M-31.97M-31.97M-27.26M-13.99M-8.72M-8.51M-8.32M
EBIT Margin0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312023-09-302023-06-302022-12-312022-06-302021-12-312021-06-302020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙